When the leading diversion-monitoring software vendor publishes a survey showing that the majority of its addressable market still has confirmed diversion events, that’s worth pausing on.
The 12th Annual Hospital Pharmacy Operations Report (HPOR), released in 2026 by Bluesight, surveyed 437 U.S. hospital pharmacy professionals. Most have more than a decade of experience. The findings on diversion are quietly damning, and not because monitoring software is failing. It”s working as designed. The problem is what “designed” means. Read More >
